MLKL and Patent ductus arteriosus: On the other hand, RIPK1/3- and MLKL-dependent necroptosis in pancreatic ductal adenocarcinoma (PDA) cells would recruit and activate immunosuppressive TAMs and myeloid cells [35, 55].